12-52544702-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_033448.3(KRT71):c.1402C>T(p.Arg468Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000626 in 1,612,360 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/23 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_033448.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KRT71 | NM_033448.3 | c.1402C>T | p.Arg468Trp | missense_variant | 9/9 | ENST00000267119.6 | NP_258259.1 | |
KRT71 | XM_047428197.1 | c.1276C>T | p.Arg426Trp | missense_variant | 8/8 | XP_047284153.1 | ||
KRT71 | XM_017018749.2 | c.1156C>T | p.Arg386Trp | missense_variant | 10/10 | XP_016874238.1 | ||
KRT71 | XM_047428196.1 | c.1030-353C>T | intron_variant | XP_047284152.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000269 AC: 41AN: 152168Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000488 AC: 12AN: 245738Hom.: 0 AF XY: 0.0000224 AC XY: 3AN XY: 133664
GnomAD4 exome AF: 0.0000411 AC: 60AN: 1460074Hom.: 0 Cov.: 57 AF XY: 0.0000372 AC XY: 27AN XY: 726400
GnomAD4 genome AF: 0.000269 AC: 41AN: 152286Hom.: 0 Cov.: 33 AF XY: 0.000269 AC XY: 20AN XY: 74460
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 22, 2021 | The c.1402C>T (p.R468W) alteration is located in exon 9 (coding exon 9) of the KRT71 gene. This alteration results from a C to T substitution at nucleotide position 1402, causing the arginine (R) at amino acid position 468 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 21, 2024 | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 468 of the KRT71 protein (p.Arg468Trp). This variant is present in population databases (rs143102155, gnomAD 0.07%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with KRT71-related conditions. ClinVar contains an entry for this variant (Variation ID: 2349747). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt KRT71 protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at